PASCALE ADAM 4
4 · HEMISPHERX BIOPHARMA INC · Filed Jun 17, 2019
Insider Transaction Report
Form 4
Pascale Adam
Chief Accounting Officer
Transactions
- Conversion
Common Stock
2019-05-08+35,000→ 147,148 total - Conversion
Common Stock
2019-03-18+50,000→ 112,148 total
Footnotes (2)
- [F1]Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the ten shares issued.
- [F2]Rights offering warrants using the cashless conversion feature, were converted into .70 number of shares.